GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
5.58
-0.17 (-2.96%)
Nov 7, 2025, 4:00 PM EST - Market closed
GlucoTrack Market Cap
GlucoTrack has a market cap or net worth of $5.02 million as of November 7, 2025. Its market cap has decreased by -56.61% in one year.
Market Cap
5.02M
Enterprise Value
-4.27M
1-Year Change
-56.61%
Ranking
Category
Stock Price
$5.58
Market Cap Chart
Since April 25, 2013, GlucoTrack's market cap has decreased from $34.13M to $5.02M, a decrease of -85.29%. That is a compound annual growth rate of -14.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 5.02M | -16.17% |
| Dec 31, 2024 | 5.99M | 9.59% |
| Dec 29, 2023 | 5.46M | -74.96% |
| Dec 30, 2022 | 21.82M | -66.12% |
| Dec 31, 2021 | 64.40M | -9.57% |
| Dec 31, 2020 | 71.22M | -26.72% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |